[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2174533T3 - Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas. - Google Patents

Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.

Info

Publication number
ES2174533T3
ES2174533T3 ES98964471T ES98964471T ES2174533T3 ES 2174533 T3 ES2174533 T3 ES 2174533T3 ES 98964471 T ES98964471 T ES 98964471T ES 98964471 T ES98964471 T ES 98964471T ES 2174533 T3 ES2174533 T3 ES 2174533T3
Authority
ES
Spain
Prior art keywords
diol
skin diseases
hydroxy acid
hyperqueratotic
alfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98964471T
Other languages
English (en)
Inventor
Agneta Ganemo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe BV filed Critical Yamanouchi Europe BV
Application granted granted Critical
Publication of ES2174533T3 publication Critical patent/ES2174533T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de una combinación de un diol y un ácido alfa-hidroxi en un vehículo para la preparación de un medicamento para el tratamiento tópico de enfermedades de la piel hiperqueratóticas, caracterizado porque el vehículo tiene propiedades semioclusivas.
ES98964471T 1997-11-25 1998-11-25 Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas. Expired - Lifetime ES2174533T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25

Publications (1)

Publication Number Publication Date
ES2174533T3 true ES2174533T3 (es) 2002-11-01

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98964471T Expired - Lifetime ES2174533T3 (es) 1997-11-25 1998-11-25 Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.

Country Status (22)

Country Link
US (1) US6399082B1 (es)
EP (1) EP1032378B1 (es)
CN (1) CN1140266C (es)
AT (1) ATE213939T1 (es)
AU (1) AU754420B2 (es)
BG (1) BG64743B1 (es)
BR (1) BR9815016A (es)
CA (1) CA2310049C (es)
CZ (1) CZ290165B6 (es)
DE (1) DE69804130T2 (es)
DK (1) DK1032378T3 (es)
ES (1) ES2174533T3 (es)
HK (1) HK1034194A1 (es)
HU (1) HU226065B1 (es)
IS (1) IS2147B (es)
NO (1) NO320100B1 (es)
NZ (1) NZ504458A (es)
PL (1) PL190023B1 (es)
PT (1) PT1032378E (es)
SK (1) SK284505B6 (es)
TR (1) TR200001486T2 (es)
WO (1) WO1999026617A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
CA2329252A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
US20030017181A1 (en) 2001-05-31 2003-01-23 Rood Gloria A. Dermatological compositions and methods
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
BRPI0708318A2 (pt) 2006-02-28 2011-05-24 Paloma Pharmaceuticals Inc composições e uso de compostos para tratar doenças caracterizadas por proliferação celular e angiogênese
US20110021618A1 (en) * 2008-03-25 2011-01-27 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
MX2011010784A (es) * 2009-04-13 2012-01-12 Sulur Subramaniam Vanangamudi Una crema medicinal con acido fusidico hecha utilizando fusidato de sodio e incorporando un biopolimero y el proceso para hacerla.
WO2010127411A1 (en) * 2009-05-08 2010-11-11 Allmedic Pty Ltd Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
CN107308163A (zh) * 2010-11-04 2017-11-03 442合资有限责任公司 用于治疗皮肤病的组合物和方法
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
NZ273329A (en) * 1993-09-15 1996-09-25 Unilever Plc Skin care preparation containing stratum corneum trypsin-like enzymes

Also Published As

Publication number Publication date
ATE213939T1 (de) 2002-03-15
PL340679A1 (en) 2001-02-12
NO20002649D0 (no) 2000-05-24
DE69804130T2 (de) 2002-07-25
HU226065B1 (hu) 2008-04-28
PL190023B1 (pl) 2005-10-31
BG104470A (en) 2001-03-30
NZ504458A (en) 2002-03-01
EP1032378B1 (en) 2002-03-06
AU754420B2 (en) 2002-11-14
SK284505B6 (sk) 2005-05-05
CZ290165B6 (cs) 2002-06-12
CN1280495A (zh) 2001-01-17
IS5505A (is) 2000-05-23
PT1032378E (pt) 2002-07-31
DE69804130D1 (de) 2002-04-11
WO1999026617A1 (en) 1999-06-03
HUP0100066A2 (hu) 2001-08-28
HUP0100066A3 (en) 2006-07-28
US6399082B1 (en) 2002-06-04
CZ20001920A3 (cs) 2001-04-11
DK1032378T3 (da) 2002-04-15
HK1034194A1 (en) 2001-10-19
EP1032378A1 (en) 2000-09-06
CN1140266C (zh) 2004-03-03
NO20002649L (no) 2000-07-24
BR9815016A (pt) 2000-10-03
TR200001486T2 (tr) 2001-07-23
AU1965999A (en) 1999-06-15
BG64743B1 (bg) 2006-02-28
CA2310049A1 (en) 1999-06-03
NO320100B1 (no) 2005-10-24
SK7432000A3 (en) 2001-05-10
CA2310049C (en) 2008-02-19
IS2147B (is) 2006-09-15

Similar Documents

Publication Publication Date Title
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
PT871473E (pt) Utilizacao de il-10 para curar feridas com cicatrizacao reduzida
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
PT1079813E (pt) Dispositivo transportador farmaceutico adequado para entrega de compostos farmaceuticos as superficies mucosas
BR0314354A (pt) Formação para gentes lipofìlicos
ES2162937T3 (es) Preparado combinado para su aplicacion en enfermedades inmunologicas.
ES2141208T3 (es) Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
DE69932510D1 (de) Vaskularisierungsinhibitoren
ES2181165T3 (es) Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas.
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
WO2003066130A3 (en) Transdermal drug delivery systems
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
AR007059A1 (es) Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto
AR011707A1 (es) Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1032378

Country of ref document: ES